ANO1 overexpression induces tumor growth in vivo and cell proliferation by activating extracellular signal-regulated kinase (ERK)1/2 via the ras-raf-MEK-ERK pathway and cyclin D1, but not activating AKT [34]. The gene discussed is ANO1; the disease is neoplasm.